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Step 2: 5'- Cloning of the muraminomicin gene cluster. Streptosporangium amethystogenes sp. SANK 60709 genomic DNA was partially digested with Sau3AI to give ~40-kb DNA fragments that were dephosphorylated with bacterial alkaline phosphatase (BAP) and ligated into BamHIdigested cosmid vector SuperCos1-P (Stratagene, Cedar Creek, USA) that contains the loxP site in SuperCos1 and was dephosphorylated by BAP after XbaI digestion. The ligation products were packaged with Gigapack III Gold packaging extract as described by the manufacturer (Stratagene), and the resulting recombinant phage was used to transfect E. coli XL-1 Blue MR. Approximately 10,000 colonies from the obtained genomic library were screened by colony hybridization using digoxigenin (DIG)-labeled DNA obtained by PCR using degenerate primers as previously described.
15 Hybridization was carried out using DIG easy hyb (Roche, Indianapolis, USA) at 42 °C and the resulting filter was washed under high stringency conditions (0.1 X SSC including 0.1 % SDS, 68 °C). Detection was performed using CDP-Star (Roche) according to the manufacturer's procedures.
Based on restriction digest analysis, four positive cosmids, pMra01-04, were isolated and sequenced using a Roche GS FLX system (Operon Biotechnologies). Potential open reading frames were defined using Frameplot 4.0, and database comparison for sequence homology was performed with BLAST search tools using the National Center for Biotechnology Information (Bethesda, MD). The sequence has been deposited at GenBank under accession no. AB746937.
Cloning of genes for heterologous expression. Genes were amplified by PCR using Expand Long Template PCR System from Roche (Indianapolis, IN) with supplied Buffer 2, 200 M dNTPs, 5% DMSO, 10 ng DNA pMra02, 5 U DNA polymerase, and 200 nM each of the following primer pairs: mra20 (forward) 5'-GGTATTGAGGGTCGCATGAACGAGAT -3' / (reverse) 5'-AGAGGAGAGTTAGAGCCTCACCCGG -3' and mra23 (forward) 5'-GGTATTGAGGGTCGCATGTCGGTCG -3' / (reverse) 5'-AGAGGAGAGTTAGAG CCTCAGCCGA -3'. The PCR program included an initial hold at 94 °C for 2 min, followed by 30 cycles of 94 °C for 10 s, 56 °C for 15 s, and 68 °C for 60 s. The gel-purified PCR product was inserted into pET-30 Xa/LIC using ligation-independent cloning as described in the provided protocol to yield pET30-mra20 and pET30-mra23. The genes were sequenced to confirm PCR fidelity.
Plasmids were introduced into E. coli BL 21(DE3) cells, and the transformed strains were grown in LB supplemented with 50 g/mL kanamycin. Following inoculation of 500 mL of LB with 50 g/mL kanamycin, the cultures were grown at 18 °C until the cell density reached an OD 600 ~ 0.5 when expression was induced with 0.1 mM IPTG. Cells were harvested after an overnight incubation at 18 °C and lysed using a French Press with one pass at 15000 psi. Following centrifugation the protein was purified using affinity chromatography with Ni-NTA agarose from Qiagen (Valencia, CA), and the recombinant proteins were desalted into 50 mM Tris-HCl (pH 8), 100 mM NaCl, and 5 % glycerol using a PD-10 desalting column (GE Healthcare). The purified protein was concentrated using an Amicon Ultra 10000 MWCO centrifugal filter (Millipore) and stored as glycerol stocks (40%) at -20 °C. Protein purity was assessed as by 12% acrylamide SDS-PAGE; His 6 -tagged proteins were utilized without further modifications.
In vitro characterization of Mra20. Reactions consisted of 25 mM potassium phosphate pH 7.5, 2 mM 2 or analogue, and 100 nM Mra20 at 30 °C, and terminated by the addition of cold TCA to 5% (w/v) or by ultrafiltration using a Microcon YM-3. Following centrifugation to remove protein, the reaction components were analyzed by HPLC using a C-18 reverse-phase column. A series of linear gradients was developed from 40 mM phosphoric acid-triethylamine pH 6.5 (A) to 20% methanol (B) in the following manner (beginning time and ending time with linear S5 increase to % B): 0-8 min, 0% B; 8-18 min, 60% B; 18-25 min, 95% B; 25-32 min, 95% B; and 32-35 min, 0% B. The flow rate was kept constant at 1.0 mL/min, and elution was monitored at 260 nm.
To determine the kinetic constants with respect to the co-substrate nucleoside, reactions were carried out in 50 mM Tris-HCl pH 9.0 consisting of saturating phosphate (1.5 mM) and variable nucleoside (25 -5,000 M), and 100 nM Mra20 at 30 °C under initial velocity conditions. The reactions were terminated with 0.1 M sodium hydroxide, and nucleobase formation was determined by UV/Vis spectroscopy with  300 nm = 3, 700 M -1 at pH 13 for 6 and  290 nm = 5, 700 M -1 at pH 13 for 5.
In vitro characterization of Mra23. Reactions consisted of 50 mM potassium phosphate pH 7.5, 5 mM MgCl 2 , 2 mM 3 or analogue, 5 mM uridine 5'-triphosphate (UTP), 5 M Mra20, and 1 M Mra23 at 30 °C, and the reaction terminated by the addition of cold TCA to 5% (w/v) or by ultrafiltration using a Microcon YM-3. The activity of ORF39 was tested with sugar-1-phosphates generated in situ from synthetic 2, 3, 4 or uridine with co-substrate UTP. Following centrifugation to remove protein, the reaction components were analyzed by HPLC using a phosphoric acid-triethylamine mobile phase as described above. LC-MS was performed using a linear gradient from 0.1% formic acid in water to 0.1% formic acid in acetonitrile over 20 min. The flow rate was kept constant at 0.4 mL/min, and elution was monitored at 254 nm. Figure S1 . Biosynthetic pathway leading to the assembly of the (1→5) disaccharide core of the lipopeptidyl nucleoside antibiotics. 
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